Vertex Pharmaceuticals (VRTX) FCF Margin (QoQ) (2009 - 2026)

Vertex Pharmaceuticals (VRTX) FCF Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3,242.00
Dec 31, 2025 -2,612.00
Sep 30, 2025 576.00
Jun 30, 2025 319.00
Mar 31, 2025 1,120.00
Dec 31, 2024 -3,008.00
Sep 30, 2024 19,146.00
Jun 30, 2024 -19,051.00
Mar 31, 2024 3,901.00
Dec 31, 2023 -4,243.00
Sep 30, 2023 633.00
Jun 30, 2023 699.00
Mar 31, 2023 -925.00
Dec 31, 2022 676.00
Sep 30, 2022 -1,086.00
Jun 30, 2022 692.00
Mar 31, 2022 -247.00
Dec 31, 2021 94.00
Sep 30, 2021 5,801.00
Jun 30, 2021 -6,322.00